Reliv' International (RELV) Competitors

Reliv' International (NASDAQ:RELV) and Hookipa Pharma (NASDAQ:HOOK) are both small-cap consumer staples companies, but which is the better business? We will compare the two companies based on the strength of their valuation, risk, earnings, dividends, institutional ownership, media sentiment, profitability, community ranking and analyst recommendations.

Which has more volatility and risk, RELV or HOOK?

Reliv' International has a beta of -0.1, indicating that its share price is 110% less volatile than the S&P 500. Comparatively, Hookipa Pharma has a beta of 0.71, indicating that its share price is 29% less volatile than the S&P 500.

Is RELV or HOOK more profitable?

Reliv' International has a net margin of -0.61% compared to Hookipa Pharma's net margin of -86.74%. Reliv' International's return on equity of -1.89% beat Hookipa Pharma's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Reliv' International	-0.61%	-1.89%	-1.31%
Hookipa Pharma	-86.74%	-33.31%	-21.65%

Which has better valuation and earnings, RELV or HOOK?

Reliv' International has higher revenue and earnings than Hookipa Pharma.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Reliv' International	$35.06M	0.17	-$440K	N/A	N/A
Hookipa Pharma	$20.13M	1.20	-$81.58M	-$3.72	-0.54

Do analysts prefer RELV or HOOK?

Hookipa Pharma has a consensus target price of $23.00, indicating a potential upside of 1,047.13%. Given Hookipa Pharma's stronger consensus rating and higher probable upside, analysts clearly believe Hookipa Pharma is more favorable than Reliv' International.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Reliv' International	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
Hookipa Pharma	0 Sell rating(s)	2 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.33

Does the media favor RELV or HOOK?

In the previous week, Hookipa Pharma had 4 more articles in the media than Reliv' International. MarketBeat recorded 4 mentions for Hookipa Pharma and 0 mentions for Reliv' International. Hookipa Pharma's average media sentiment score of 0.93 beat Reliv' International's score of 0.00 indicating that Hookipa Pharma is being referred to more favorably in the news media.

Company	Overall Sentiment
Reliv' International	Neutral
Hookipa Pharma	Positive

Do insiders & institutionals believe in RELV or HOOK?

8.0% of Reliv' International shares are held by institutional investors. Comparatively, 63.9% of Hookipa Pharma shares are held by institutional investors. 31.2% of Reliv' International shares are held by insiders. Comparatively, 3.3% of Hookipa Pharma shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Does the MarketBeat Community believe in RELV or HOOK?

Reliv' International received 13 more outperform votes than Hookipa Pharma when rated by MarketBeat users. Likewise, 70.27% of users gave Reliv' International an outperform vote while only 69.47% of users gave Hookipa Pharma an outperform vote.

Company	Underperform	Outperform
Reliv' International	Outperform Votes 104 70.27%	Underperform Votes 44 29.73%
Hookipa Pharma	Outperform Votes 91 69.47%	Underperform Votes 40 30.53%

Summary

Hookipa Pharma beats Reliv' International on 9 of the 17 factors compared between the two stocks.